Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ovarian cancer: Current status and strategies for improving therapeutic outcomes
Ashwin Chandra, Cima Pius, Madiha Nabeel, et al.
Cancer Medicine (2019) Vol. 8, Iss. 16, pp. 7018-7031
Open Access | Times Cited: 316

Showing 1-25 of 316 citing articles:

Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics
Kavita R. Gajbhiye, Rajesh Salve, Mahavir Narwade, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 73
Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions
Aleksandra Zoń, Ilona Bednarek
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7585-7585
Open Access | Times Cited: 64
Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer
Asif Ahmad Bhat, Ahsas Goyal, Riya Thapa, et al.
Cytokine (2023) Vol. 171, pp. 156376-156376
Closed Access | Times Cited: 48
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1845-1845
Open Access | Times Cited: 29
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)
Luca Falzone, Giuseppa Scandurra, Valentina Lombardo, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 1
Open Access | Times Cited: 88
Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
Salima Akter, Md. Ataur Rahman, Mohammad Nazmul Hasan, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 650-650
Open Access | Times Cited: 62
Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer
Urushi Rehman, Neha Parveen, Afsana Sheikh, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 218, pp. 112766-112766
Closed Access | Times Cited: 49
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Kharimat Lora Alatise, Samantha Gardner, Angela Alexander-Bryant
Cancers (2022) Vol. 14, Iss. 24, pp. 6246-6246
Open Access | Times Cited: 46
Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization
Zong Xia Zhao, Ting Shuang, Yan Gao, et al.
Cancer Letters (2022) Vol. 530, pp. 45-58
Closed Access | Times Cited: 43
The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer
Bryce Wallis, Katherine E. Redd Bowman, Phong Lu, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 159-159
Open Access | Times Cited: 33
Moringa oleifera gum capped MgO nanoparticles: Synthesis, characterization, cyto- and ecotoxicity assessment
Sekar Vijayakumar, Jingdi Chen, Zaira I. González Sánchez, et al.
International Journal of Biological Macromolecules (2023) Vol. 233, pp. 123514-123514
Closed Access | Times Cited: 24
Advances in pharmacological effects and mechanism of action of cinnamaldehyde
Jiageng Guo, Shidu Yan, Xinya Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
GALNT14 Regulates Ferroptosis and Apoptosis of Ovarian Cancer Through the EGFR/mTOR Pathway
Huawen Li, Mubiao Liu, Xue Jiang, et al.
Future Oncology (2021) Vol. 18, Iss. 2, pp. 149-161
Open Access | Times Cited: 43
The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
Sebastian Stępień, Paweł Olczyk, Joanna Gola, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1118-1118
Open Access | Times Cited: 21
Cancer Cell Membrane-Enveloped Dexamethasone Normalizes the Tumor Microenvironment and Enhances Gynecologic Cancer Chemotherapy
Mingzhuang Li, Yingyao Wang, Lin Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16703-16714
Closed Access | Times Cited: 21
Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review
Mehrab Pourmadadi, Ali Moammeri, Amin Shamsabadipour, et al.
Biosensors (2023) Vol. 13, Iss. 1, pp. 99-99
Open Access | Times Cited: 20
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
Lavanya Varier, Sumati Sundaram, Naisarg Gamit, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1275-1275
Open Access | Times Cited: 19
Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy
Nastaran Masoudi-Khoram, Mohammad Hasan Soheilifar, Shima Ghorbanifar, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 185, pp. 103967-103967
Closed Access | Times Cited: 18
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 7
Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review
Effat Alemzadeh, Leila Allahqoli, Afrooz Mazidimoradi, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 831-847
Open Access | Times Cited: 6
Aberrant sialylation in ovarian cancers
Wen-Ling Lee, Peng‐Hui Wang
Journal of the Chinese Medical Association (2020) Vol. 83, Iss. 4, pp. 337-344
Open Access | Times Cited: 49
The role of caspase-8 in the tumor microenvironment of ovarian cancer
Izabela Kostova, Ranadip Mandal, Sven Becker, et al.
Cancer and Metastasis Reviews (2020) Vol. 40, Iss. 1, pp. 303-318
Open Access | Times Cited: 46
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
Chen-Yu Huang, Min Cheng, Na-Rong Lee, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 7, pp. 2213-2213
Open Access | Times Cited: 42
HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p
Hongtu Chao, Mengli Zhang, Hongyi Hou, et al.
Life Sciences (2020) Vol. 243, pp. 117296-117296
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top